We use cookies in this website. Read about them in our privacy policy. To disable them, configure your browser properly. If you keep using this website, you are accepting those.
OK
Logo of Luxembourg Institute of Health
  • Home
  • Researchers
  • Public
  • Press
  • COVID-19
  • Research
    • Priority research topics
      • Cancer
      • Immunological disorders
      • Neurodegenerative diseases
      • Preventive medicine
    • Research A-Z
      • Scientists
      • Research Groups
    • Departments
      • Department of Infection and Immunity
      • Department of Oncology
      • Department of Population Health
    • Scientific platforms
      • Clinical and Epidemiological Investigation Centre (CIEC)
      • Integrated BioBank of Luxembourg (IBBL)
      • Methodology and Statistics
      • Quantitative Biology Unit
    • Transversal Translational Medicine (TTM)
    • Scientific publications
  • Research support
    • Research support
      • Business Development Office
      • Compliance Office
      • Doctoral Training
      • Science Office
  • News
  • Events
  • Training
  • Career
  • About us
    • About us
      • Mission & Vision
      • Governance
      • Activity Reports
    • Find us
  • My cart


 Introduction to LIH
   Official Presentation Video

  Watch the video!



 

  CORONAVIRUS (COVID-19):
 
A PRIORITY FOR LIH

     Read more 



 

  Focus on
  Translational Medicine

     Read more 



  Search by
  RESEARCH TOPICS

     Discover 



  Search by
  SCIENTIFIC PLATFORMS

     Discover 



  Search by
  RESEARCH GROUPS

     Discover 



  Search by
  SCIENTISTS

     Discover 


News
Events
Jobs
News
Boosting the immune system against COVID-19
Dr. Torsten Bohn, leader of the Nutrition and Health Research Group at the LIH Department of Population Health (DoPH), together with co-first authors Mohammed Iddir (PhD Student) and Dr. Alex Brito, recently published an article reviewing the importance of an optimal status of specific nutrients and additional dietary constituents to effectively aid in controlling inflammation and oxidative stress, thereby strengthening the immune system during the COVID-19 crisis.
News
Elucidating the roles of atypical chemokine receptors in cancer: from molecular biology to clinical relevance and therapy
Max Meyrath, Dr Andy Chevigné and Dr Martyna Szpakowska from the Immuno-Pharmacology and Interactomics research group of the Department of Infection and Immunity (DII) published a book chapter on cancer signalling, in collaboration with international partners. The scientific publication, which was released in February 2020 in Advances in Cancer Research, reviews the roles of atypical chemokine receptors (ACKRs) in the different phases of cancer development, progression and metastasis, their clinical relevance, as well as their implications for cancer therapy.
News
Second FNR COVID-19 Fast Track Call results
On Friday, May 29th, the Luxembourg National Research Fund (Fonds National de la Recherche - FNR) announced the results of the second round of financing under its novel COVID-19 Fast Track Call. A total of 21 out of the 55 eligible projects were retained for funding, corresponding to an FNR commitment of EUR 1.12 million. Namely, four LIH projects are among the selected ones, for a total support amounting to over EUR 197,000.
News
Predi-COVID - Behind the scenes
On April 24th, the Research Luxembourg Taskforce officially launched “Predi-COVID” (Luxembourg cohort of positive patients for COVID-19: a stratification study to predict severe prognosis»), a study led by the Department of Population Health (DoPH) of the Luxembourg Institute of Health (LIH).
News
CON-VINCE study results – second testing phase
CON-VINCE, a national research project aiming to evaluate the prevalence and dynamics of the spread of COVID-19 within the Luxembourgish population, was launched at the beginning of April under the umbrella of the Research Luxembourg COVID-19 Task Force.
News
[Article series] The experts behind Luxembourg’s Covid-19 fight
Prof Rejko Krüger is the Director of Transversal Translational Medicine (TTM) at LIH.
News
CON-VINCE Study - Behind the scenes (PART I)
On 8th April, the CON-VINCE study was officially launched, with the aim to assess the spread dynamics of the COVID-19 disease among the Luxembourgish population.
News
Large scale COVID-19 testing
As part of the deconfinement, Luxembourg is calling on its residents and cross-border workers to get tested for COVID-19. It aims to limit the spread of the novel corona virus by voluntary extensive testing until the end of July. This will allow to break infection chains and thus protect family, friends and colleagues. The more tests are carried out, the more new infections can be prevented and the safer everyday life will be.
News
[Article series] The experts behind Luxembourg’s Covid-19 fight
Prof Claude P. Muller is a medical doctor and chemist by training. As a scientist, he works in the surveillance and management of viral outbreaks at a global level.
  • Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Stay in touch

Sign up to LIH's Newsletter

Subscribe Thanks
Thanks for your subscription!

Support LIH

Get involved, and support biomedical research ! 100% of donations are used for our research projects.

Make a donation

Follow US

  • Facebook
  • Linkedin
  • Twitter
  • Youtube
  • Instagram
  • Researchers
    • PRiority research topics
    • Research groups A-Z
    • scientific platforms 
    • Transversal Translational Medicine (TTM)
  • NEWS
  • EVENTS
  • TRAINING

  • About us
    • Mission & vision
    • Governance
    • Activity reports
  • Find us
  • Jobs
  • Press
  • LOGIN
Powered by Odoo, the #1 Open Source eCommerce.
Copyright © Luxembourg Institute of Health- Terms of use - Privacy Policy - Legal Advice
Logo of Luxembourg Institute of Health
  • Terms & conditions | Data Privacy

Copyright © 2021 - Luxembourg institute of health - Lih.lu - all rights reserved